Genital Herpes Drug Doesn’t Reduce HIV Risk

Washington (dbTechno) - It is back to the drawing board to fight HIV as an experiment to treat genital herpes with a genital herpes drug to reduce the risk of HIV infection has failed.

Researchers found that the genital herpes drug gave no extra protection at all against the HIV infection.

The study was released on Monday at the 15th annual Retrovirus conference and was a huge blow to researchers as they were hopeful it would slow AIDS.

Over the course of the past two decades they found that herpes infections tripled the risk of getting HIV.

The idea was to use a common genital herpes drug, acyclovir, to stop the infection, thus protecting against HIV.

What they found in the study though was disappointing, as the genital herpes drug did nothing to stop the HIV infections.

Kevin DeCock of the World Health Organization’s Department of HIV/AIDS stated “We we really need is a herpes vaccine.”